Precision Medicine

Does Mutation Severity Override Female Resilience in Autism?
Tech & Innovation Does Mutation Severity Override Female Resilience in Autism?

The persistent clinical observation that males are diagnosed with autism spectrum disorder at nearly four times the rate of females has remained one of the most enduring and complex enigmas in modern neurobiology. For decades, scientists have operated under the hypothesis of a female protective

How Can AI Design Quasisymmetric Protein Nanocages?
Tech & Innovation How Can AI Design Quasisymmetric Protein Nanocages?

Nature has perfected the art of molecular architecture over billions of years, creating viral capsids that serve as the gold standard for structural efficiency and protective capability. These biological shells are composed of hundreds or even thousands of identical protein subunits that

Can a Global Clinical Trial Stop This Rare Brain Disease?
Research & Development Can a Global Clinical Trial Stop This Rare Brain Disease?

The diagnosis of a rare neurodegenerative condition often leaves families in a state of profound uncertainty as they navigate a medical landscape with few answers and even fewer treatment options. For David Booth, a retired builder from the United Kingdom, the journey began not with a sudden

Algorae Pharmaceuticals Expands AI Drug Discovery Program
Tech & Innovation Algorae Pharmaceuticals Expands AI Drug Discovery Program

The pharmaceutical industry has long grappled with the overwhelming complexity of human biology, where the cost and time required to bring a single therapeutic candidate to market often exceed the financial capabilities of all but the largest global entities. Traditional drug discovery has

Who Truly Owns Your Medical Data in the Digital Age?
Tech & Innovation Who Truly Owns Your Medical Data in the Digital Age?

The transition from traditional paper charts to sophisticated digital health ecosystems has fundamentally redefined the boundary between a patient’s private life and the institutional machinery of modern medicine. When an individual steps into a high-tech clinic in 2026, they are often greeted not

Study Identifies p53 Mutants Sensitive to APR-246 in Ovarian Cancer
Research & Development Study Identifies p53 Mutants Sensitive to APR-246 in Ovarian Cancer

Ovarian cancer continues to represent a formidable obstacle in gynecologic oncology, largely because the disease is frequently detected at advanced stages and tends to develop rapid resistance to standard therapeutic interventions. At the core of this malignancy’s formidable resilience is the TP53

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later